StockData
Anavex Life Sciences Corp. logo

Anavex Life Sciences Corp. (AVXL) stock

AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 28, 2026Score 6/30
$0.72−0.02 (-2.78%)

Close on Nov 18, 2026Market cap $66.69MP/E –Yield –

Anavex Life Sciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Anavex Life Sciences

Anavex Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Anavex Life Sciences figures

See a number that looks wrong?